Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-29T02:46:58.334Z Has data issue: false hasContentIssue false

35 - Botulinum Toxin Therapy for Spasmodic Dysphonia

from Section II - Botulinum Toxin Therapy

Published online by Cambridge University Press:  31 May 2018

By
Christopher Tang  and
Andrew Blitzer
Edited by
Dirk Dressler ,
Eckart Altenmüller  and
Joachim K. Krauss
Dirk Dressler
Affiliation:
Hannover Medical School
Eckart Altenmüller
Affiliation:
Hochschule für Musik, Theater und Medien, Hannover
Joachim K. Krauss
Affiliation:
Hannover Medical School
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment of Dystonia , pp. 172 - 177
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adler, CH, Bansberg, SF, Krein-Jones, K, Hentz, JG. 2004. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia. Mov Disord 19(9): 1075–1079.CrossRefGoogle ScholarPubMed
Aronson, AE, De Santo, LW. 1983. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope 93(1): 1–8.CrossRefGoogle ScholarPubMed
Aronson, AE, Lagerlund, TD. 1991. Neuroimaging studies do not prove the existence of brain abnormalities in spastic (spasmodic) dysphonia. J Speech Hear Res 34(4): 801–811.CrossRefGoogle Scholar
Aronson, AE, Brown, JR, Litin, EM, Pearson, JS. 1968. Spastic dysphonia: I. Voice, neurologic, and psychiatric aspects. J Speech Hear Disord 33(3): 203–218.CrossRefGoogle ScholarPubMed
Atassi, MZ. 2004. Basic immunological aspects of botulinum toxin therapy. Mov Disord 19(Suppl. 8): S68–S84.CrossRefGoogle ScholarPubMed
Atassi, MZ. 2009. Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action. Toxicon 54(5):600–613.CrossRefGoogle Scholar
Atassi, MS, Dolimbek, BZ, Jankovic, J, Steward, LE, Aoki, KR. 2011. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment: the antigenic structure of the active toxin recognized by human antibodies. Immunobiology 216(7):782–792.CrossRefGoogle ScholarPubMed
Berke, GS, Blackwell, KE, Gerratt, BR, Verneil, A, Jackson, KS, Sercarz, JA. 1999. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 108(3): 227–231.CrossRefGoogle ScholarPubMed
Bielamowicz, S, Stager, SV, Badillo, A. Godlewski, A. 2002. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. J Voice 16(1): 117–123.CrossRefGoogle ScholarPubMed
Blitzer, A. 2005. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia. Otolaryngol Head Neck Surg 133(6): 836–838.CrossRefGoogle Scholar
Blitzer, A, Lovelace, RE, Brin, MF, Fahn, S, Fink, ME. 1985. Electromyographic findings in focal laryngeal dystonia (spastic dysphonia). Ann Otol Rhinol Laryngol 94(6 Pt 1): 591–594.Google Scholar
Blitzer, A, Brin, MF, Stewart, CF. 1998. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 108(10): 1435–1441.Google Scholar
Carlsoo, B, Izdebski, K, Dahlqvist, A, Domeij, S, Dedo, HH. 1987. The recurrent laryngeal nerve in spastic dysphonia: a light and electron microscopic study. Acta Otolaryngol 103(1–2): 96–104.CrossRefGoogle ScholarPubMed
Chhetri, DK, Blumin, JH, Vinters, HV, Berke, GS. 2003. Histology of nerves and muscles in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 112(4): 334–341.CrossRefGoogle ScholarPubMed
Critchley, M. 1939. Spastic dysphonia ‘inspiratory speech’. Brain 62: 96–103.Google Scholar
Dedo, HH. 1976. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 85(4 Pt 1): 451–459.Google Scholar
Dedo, HH, Izdebski, K. 1984. Evaluation and treatment of recurrent spasticity after recurrent laryngeal nerve section: a preliminary report. Ann Otol Rhinol Laryngol 93(4 Pt 1): 343–345.Google Scholar
Feldman, M, Nixon, JV, Finitzo-Hieber, T, Freeman, FJ. 1984. Abnormal parasympathetic vagal function in patients with spasmodic dysphonia. Ann Intern Med 100(4): 491–495.Google Scholar
Finitzo-Hieber, T, Freeman, FJ, Gerling, IJ, Dobson, L, Schaefer, SD. 1982. Auditory brainstem response abnormalities in adductor spasmodic dysphonia. Am J Otolaryngol 3(1): 26–30.Google Scholar
Hillel, AD, Maronian, NC, Waugh, PF, Robinson, L, Klotz, DA. 2004. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia. Ann Otol Rhinol Laryngol 113(5): 341–348.CrossRefGoogle ScholarPubMed
Isshiki, N, Yamamoto, I, Fukagai, S. 2004. Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge. Acta Otolaryngol 124(3): 309–312.CrossRefGoogle ScholarPubMed
Jacome, DE, Yanez, GF. 1980. Spastic dysphonia and Meigs disease. Neurology 30(4): 349.Google Scholar
Marsden, CD, Sheehy, MP. 1982. Spastic dysphonia, Meige disease, and torsion dystonia. Neurology 32(10): 1202–1203.Google Scholar
Meyer, T, Blitzer, A. 2006. Spasmodic dysphonia. In: Stacy, M, ed. Handbook of Dystonia. London: CRC Press, pp. 179–188.CrossRefGoogle Scholar
Murry, T, Woodson, GE. 1995. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. J Voice 9(4): 460–465.CrossRefGoogle ScholarPubMed
Netterville, JL, Stone, RE, Rainey, C, Zealear, DL, Ossoff, RH. 1991. Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 100(1): 10–14.CrossRefGoogle ScholarPubMed
Newton-John, H. 1988. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. BMJ 297(6654): 964–965.CrossRefGoogle ScholarPubMed
N‘ovakovic, D, Waters, HH, D'Elia, JB, Blitzer, A. 2011. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope 121(3): 606–612.CrossRefGoogle Scholar
Ravits, JM, Aronson, AE, DeSanto, LW, Dyck, PJ. 1979. No morphometric abnormality recurrent laryngeal nerve in spastic dysphonia. Neurology 29(10): 1376–1382.CrossRefGoogle ScholarPubMed
Roark, RM, Dowling, EM, DeGroat, RD, Watson, BC, Schaefer, SD. 1995. Time-frequency analyses of thyroarytenoid myoelectric activity in normal and spasmodic dysphonia subjects. J Speech Hear Res 38(2): 289–303.Google Scholar
Sapienza, CM, Walton, S, Murry, T. 2000. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. J Voice 14(4): 502–520.Google Scholar
Schaefer, SD. 1983. Neuropathology of spasmodic dysphonia. Laryngoscope 93(9): 1183–1204.CrossRefGoogle ScholarPubMed
Schaefer, S, Freeman, F, Finitzo, T, Close, L, Cannito, M, Ross, E, Reisch, J, Maravilla, K. 1985. Magnetic resonance imaging findings and correlations in spasmodic dysphonia patients. Ann Otol Rhinol Laryngol 94(6 Pt 1): 595–601.CrossRefGoogle ScholarPubMed
Schaefer, SD, Finitzo-Hieber, T, Gerling, IJ, Freeman, FJ. 1983. Brainstem conduction abnormalities in spasmodic dysphonia. Ann Otol Rhinol Laryngol 92(1 Pt 1): 59–64.Google Scholar
Traube, L. 1871. Zur Lehre von den Larynxaffectionen beim Ileotyphus. Berlin: Verlag Van August Hisschwald, pp. 674–678.Google Scholar
Tucker, HM. 1989. Laryngeal framework surgery in the management of spasmodic dysphonia: preliminary report. Ann Otol Rhinol Laryngol. 98(1 Pt 1): 52–54.CrossRefGoogle ScholarPubMed
Van Pelt, F, Ludlow, CL, Smith, PJ. 1994. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 103(3): 192–200.CrossRefGoogle ScholarPubMed
Warren, J, Thompson, P. 1998. Drug-induced supraglottic dystonia and spasmodic dysphonia. Mov Disord 13(6): 978–979.Google Scholar
Weed, DT, Jewett, BS, Rainey, C, Zealear, DL, Stone, RE, Ossoff, RH, Netterville, JL. 1996. Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 105(8): 592–601.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×